n-valyltryptophan has been researched along with norethindrone in 1 studies
| Studies (n-valyltryptophan) | Trials (n-valyltryptophan) | Recent Studies (post-2010) (n-valyltryptophan) | Studies (norethindrone) | Trials (norethindrone) | Recent Studies (post-2010) (norethindrone) |
|---|---|---|---|---|---|
| 13 | 0 | 6 | 4,295 | 884 | 303 |
| Protein | Taxonomy | n-valyltryptophan (IC50) | norethindrone (IC50) |
|---|---|---|---|
| Estrogen receptor | Homo sapiens (human) | 0.808 | |
| Glucocorticoid receptor | Homo sapiens (human) | 0.433 | |
| Progesterone receptor | Homo sapiens (human) | 0.0032 | |
| Glycine receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.433 | |
| Androgen receptor | Rattus norvegicus (Norway rat) | 0.0711 | |
| Glycine receptor subunit beta | Rattus norvegicus (Norway rat) | 0.433 | |
| Glycine receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.433 | |
| Glycine receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.433 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 4.537 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, DE; Frenkel, D; Li, J; Murray, CW; Robson, B; Waszkowycz, B; Westhead, DR | 1 |
1 other study(ies) available for n-valyltryptophan and norethindrone
| Article | Year |
|---|---|
PRO_LIGAND: an approach to de novo molecular design. 2. Design of novel molecules from molecular field analysis (MFA) models and pharmacophores.
Topics: Angiotensin-Converting Enzyme Inhibitors; Drug Design; Ligands; Receptors, Androgen; Receptors, Progesterone; Software; Steroids; Structure-Activity Relationship | 1994 |